Natrol Reports First Quarter Earnings.CHATSWORTH, Calif. -- Natrol, Inc. (NASDAQ:NTOL) today announced financial results for the quarter ended March 31, 2005. The Company recorded a net loss of $592,000 or $0.04 per share for the quarter ended March 31, 2005 as compared to net income of $450,000 or $0.03 per share in the quarter ended March 31, 2004. Net sales decreased 13.5%, or $2.7 million, to $17.7 million for the three months ended March 31, 2005 from $20.4 million for the three months ended March 31, 2004. Elliott Balbert, Natrol's President and Chairman, advised that "Sales of one product in our weight loss category fell approximately $2 million," and additionally noted that "our Prolab brand also suffered a $1.1 million drop in business when compared to 2004. Consumers moving away from low-carb diets affected our weight loss category and increases in the cost of whey forced a price increase which affected the Prolab business. The bottom line was affected heavily by legal expenses that were approximately $554,000 more in the first quarter of 2005 than in the first quarter of 2004. This was due to the timing of litigation and the final settlement of litigation surrounding Andro-based products sold by Prolab prior to August 2002. We believe the current quarter is not a predictor of how the year will finish. Our balance sheet remains strong, and the Company is optimistic that product introductions such as the new line of innovative Brainspeed(TM) products, which has been announced but has not yet shipped, will perform well." The statements made in this press release which are not historical facts including statements regarding expectations for future growth of revenue and profits and trends concerning net sales, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. As a result of a number of factors, the Company's actual results could differ materially from those set forth in the forward-looking statements. Certain factors that might cause Natrol's actual results to differ materially from those set forth in the forward-looking statements include adverse trends in the dietary supplements industry, intense competition, adverse effects of unfavorable publicity regarding particular products or the Company's industry generally, the Company's dependence on the introduction of successful new products, the Company's ability to gain market share and shelf space in each of its distribution channels, the Company experiencing high rates of product returns, and adverse government regulation, as well as those factors set forth under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2004 and in the Company's other filings with Securities and Exchange Commission.
Natrol, Inc. and Subsidiaries
Consolidated Balance Sheets
(In thousands, except share and per share data)
March 31,
2005
-----------
(Unaudited)
Assets
Current assets:
Cash $ 6,947
Accounts receivable, net of allowances of $404 and $421
at March 31, 2005 and December 31, 2004, respectively 7,705
Inventory 9,009
Income taxes receivable 862
Deferred income taxes 814
Prepaid expenses and other current assets 761
-----------
Total current assets 26,098
-----------
Property and equipment:
Land, building and improvements 15,891
Machinery and equipment 5,460
Furniture and office equipment 3,114
-----------
24,465
Accumulated depreciation (8,342)
-----------
Property and equipment, net 16,123
-----------
Restricted cash 5,000
Deferred income taxes 3,628
Goodwill, net of accumulated amortization and impairment
charge of $37,381 2,026
Other assets 192
-----------
Total assets $53,067
===========
Liabilities and stockholders' equity
Current liabilities:
Accounts payable $ 3,708
Accrued expenses 2,917
Accrued payroll and related liabilities 1,140
Current portion of long-term debt 510
-----------
Total current liabilities 8,275
-----------
Long-term debt, less current portion 7,566
Commitments and contingencies
Stockholders' equity:
Preferred stock, par value of $0.01 per share:
Authorized shares--2,000,000; Issued and
outstanding shares-none
Common stock, par value of $0.01 per share:
Authorized shares--50,000,000
Issued and outstanding shares-14,310,715 and 14,281,928
at March 31, 2005 and December 31, 2004, respectively 143
Additional paid-in capital 62,766
Accumulated deficit (22,802)
-----------
40,107
Shares held in treasury, at cost-921,900 shares at
March 31, 2005 and December 31, 2004 (2,881)
-----------
Total stockholders' equity 37,226
-----------
Total liabilities and stockholders' equity $53,067
===========
Natrol, Inc. and Subsidiaries
Consolidated Statements of Operations
(In thousands, except share and per share data)
Three Months Ended
March 31,
-----------------------
2005 2004
----------- -----------
(Unaudited)
Net sales $17,669 $20,425
Cost of goods sold 11,404 12,595
----------- -----------
Gross profit 6,265 7,830
----------- -----------
Selling and marketing expenses 4,185 4,619
General and administrative expenses 2,917 2,325
----------- -----------
Total operating expenses 7,102 6,944
----------- -----------
Operating income (loss) (837) 886
Interest income 42 22
Interest expense (160) (158)
----------- -----------
Income (loss) before income taxes (955) 750
Income tax (benefit) provision (363) 300
----------- -----------
Net Income (loss) $ (592) $ 450
=========== ===========
Basic and Diluted income (loss) per share:
----------- -----------
Income (loss) per share $ (0.04) $ 0.03
=========== ===========
Weighted-average shares outstanding:
Basic 13,384,419 13,162,459
Diluted 13,384,419 14,175,061
|
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion